Inhibition of the Nrf2-TrxR Axis Sensitizes the Drug-Resistant Chronic Myelogenous Leukemia Cell Line K562/G01 to Imatinib Treatments
doi 10.26434/chemrxiv.9755543.v1
Full Text
Open PDFAbstract
Available in full text
Date
September 3, 2019
Authors
Publisher
American Chemical Society (ACS)